Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Design Therapeutics (DSGN) Forecast
NewsEarningsDesign Therapeutics (DSGN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Design Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DSGN | Benzinga
Explore Design Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DSGN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Design Therapeutics (DSGN) stock?
You can purchase shares of Design Therapeutics (NASDAQ:DSGN) through any online brokerage.
Who are Design Therapeutics (DSGN) competitors?
Other companies in Design Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), CytomX Therapeutics (NASDAQ:CTMX), Voyager Therapeutics (NASDAQ:VYGR), Monopar Therapeutics (NASDAQ:MNPR) and Tevogen Bio Holdings (NASDAQ:TVGN).
What is the forecast, or price target, for Design Therapeutics (DSGN) stock?
Design Therapeutics has a consensus price target of $6.75.
What is the current price for Design Therapeutics (DSGN)?
The stock price for Design Therapeutics (NASDAQ: DSGN) is $3.48 last updated May 14, 2025 at 9:52 AM EDT.
Does Design Therapeutics (DSGN) pay a dividend?
There are no upcoming dividends for Design Therapeutics.
When is Design Therapeutics (NASDAQ:DSGN) reporting earnings?
Design Therapeutics’s Q2 earnings are confirmed for Monday, August 4, 2025.
Is Design Therapeutics (DSGN) going to split?
There is no upcoming split for Design Therapeutics.
What sector and industry does Design Therapeutics (DSGN) operate in?
Design Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
